Comparative Study to Evaluate the Efficacy and Safety of the Fixed-dose Combination of Estradiol / Dydrogesterone in Perimenopausal Women

NCT05156814 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Perimenopausal Disorder
Hot Flashes

Interventions

DRUG: Femoston® 1, Femoston® 2
DRUG: Duphaston
DRUG: Klimadynon
DRUG: Divigel

Sponsor

Scientific Research Institute of Public Health, Russian Federation